Clinical characteristics and exercise capacity data according to tertiles of peak-ex BNP level
Whole Cohort n=211 | Tertile 1 (6–42 pg/mL) n=71 | Tertile 2 (43–91 pg/mL) n=70 | Tertile 3 (92–956 pg/mL) n=70 | p Value† | |
---|---|---|---|---|---|
Clinical data | |||||
Age, years | 68±11 | 65±12 | 69±10* | 69±10* | 0.03 |
Male gender, % | 64% | 63% | 66% | 63% | 0.91 |
Height, cm | 167±8 | 167±7 | 168±10 | 166±8 | 0.50 |
Weight, kg | 74±13 | 76±12 | 76±12 | 72±13 | 0.21 |
Body surface area, m2 | 1.82±0.18 | 1.82±0.18 | 1.83±0.18 | 1.81±0.19 | 0.71 |
Body mass index, kg/m2 | 26.6±3.7 | 27.1±3.9 | 26.8±3.5 | 26.0±3.6 | 0.27 |
Heart rate, beats/min | 70±12 | 71±12 | 70±10 | 70±13 | 0.99 |
History of hypertension, % | 53% | 57% | 49% | 53% | 0.65 |
Systolic blood pressure, mm Hg | 141±21 | 142±24 | 139±17 | 142±21 | 0.71 |
Diastolic blood pressure, mm Hg | 77±11 | 79±11 | 74±10* | 77±11 | 0.04 |
Hypercholesterolaemia, % | 46% | 48% | 43% | 47% | 0.83 |
Diabetes, % | 14% | 13% | 12% | 17% | 0.44 |
History of smoking, % | 27% | 24% | 31% | 28% | 0.65 |
Resting BNP level, pg/mL | 43 (24–81) | 16 (9–26) | 45 (39–60) | 101 (76–133) | By design |
Exercise testing data | |||||
Duration, min | 9.1±3.1 | 9.0±2.6 | 8.9±2.9 | 9.4±3.6 | 0.69 |
Peak-ex workload, watts | 99±35 | 102±38 | 101±35 | 94±33 | 0.35 |
Peak-ex heart rate, beats/min | 120±19 | 124±20 | 119±16 | 118±19 | 0.13 |
Percent of predicted maximal heart rate, % | 91±12 | 92±12 | 91±11 | 90±14 | 0.83 |
Peak-ex systolic blood pressure, mm Hg | 179±23 | 184±23 | 177±24 | 177±22 | 0.17 |
Peak-ex diastolic blood pressure, mm Hg | 87±14 | 90±14 | 85±14 | 86±13 | 0.09 |
Peak-ex BNP level, pg/mL | 58 (29–115) | 20 (13–30) | 59 (53–74) | 146 (115–201) | By design |
Values are mean±SD except for BNP data which are median (IQR).
†p Value of the one-way ANOVA. The following symbols indicate the significance of the Tukey's post hoc test: *p<0.05 from ‘Tertile 1’.
BNP, B-type natriuretic peptide; Peak-ex, peak-exercise.